Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen? (Record no. 26281418)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01446 a2200433 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517110417.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201711s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2363-8915 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1515/dmpt-2016-0006 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Falvella, Felicia Stefania |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20171110 |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen? |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Drug metabolism and personalized therapy |
| Date of publication, distribution, etc. | 09 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 157-63 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Alleles |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Child |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytochrome P-450 CYP2C9 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytochrome P-450 CYP3A |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Genotype |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Losartan |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Marfan Syndrome |
| General subdivision | drug therapy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marelli, Susan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cheli, Stefania |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Montanelli, Stefano |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Viecca, Federico |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Salvi, Lucia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ferrara, Alfio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Clementi, Emilio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trifirò, Giuliana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pini, Alessandro |
| 773 0# - HOST ITEM ENTRY | |
| Title | Drug metabolism and personalized therapy |
| Related parts | vol. 31 |
| -- | no. 3 |
| -- | p. 157-63 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1515/dmpt-2016-0006">https://doi.org/10.1515/dmpt-2016-0006</a> |
| Public note | Available from publisher's website |
No items available.